Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 5
Submit an article Journal homepage
236
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series

Pablo Guisado-VascoHospital Ramón y Cajal, Madrid, Spain
,
Reyes Arranz-SaezHospital de La Princesa, Madrid, Spain
,
Miguel CanalesHospital La Paz, Madrid, Spain
,
Araceli CánovasHospital de Cruces, Baracaldo, Bilbao, Spain
,
José Garcia-LarañaHospital Ramón y Cajal, Madrid, Spain
,
Ramón García-SanzHospital Universitario de Salamanca, Salamanca, Spain
,
Andrés LopezHospital Vall d'Hebron, Barcelona, Spain
,
José Luis LópezFundación Jiménez Díaz, Madrid, Spain
,
Marta LlanosHospital Universitario de Canarias, Tenerife, Spain
,
José Maria MoraledaHospital Universitario Virgen de la Arrixaca, Murcia, Spain
,
José RodriguezHospital Son Dureta, Palma de Mallorca, Spain
,
Consuelo RayónHospital Central de Asturias, Oviedo, Spain
,
Pilar SabinHospital Gregorio Marañón, Madrid, Spain
,
Antonio SalarHospital del Mar, Barcelona, Spain
,
Ana Marín-NieblaHospital Virgen del Rocío, Sevilla, Spain
,
Manuel MorenteMolecular Pathology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
,
Pedro Sánchez-GodoyHospital Severo Ochoa, Madrid, Spain
,
José Francisco TomásM. D. Anderson España, Madrid, Spain
,
Alfonso MurielHospital Ramón y Cajal, Madrid, Spain;IRYCIS, CIBERESP, Madrid, Spain
,
Victor AbrairaHospital Ramón y Cajal, Madrid, Spain;IRYCIS, CIBERESP, Madrid, Spain
,
Miguel A. PirisHospital Marqués de Valdecilla, Santander, Spain
,
Juán F. GarciaMolecular Pathology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain;M. D. Anderson España, Madrid, Spain
,
Carlos MontalbanHospital Ramón y Cajal, Madrid, SpainCorrespondence[email protected]
& for the Spanish Hodgkin Lymphoma Study Group show all
Pages 812-819 | Received 26 Aug 2011, Accepted 18 Oct 2011, Published online: 31 Jan 2012

References

  • Canellos GP, Anderson JR, Propert KJ, . Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992;327:1478–1484.
  • Sánchez-Aguilera A, Montalbán C, de la Cueva P, . Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 2006;108:662–668.
  • Sánchez-Espiridon B, Sánchez-Aguilera A, Montalbán C, . A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples. Clin Cancer Res 2009;15:1367–1375.
  • Sánchez-Espiridión B, Montalbán C, López A, . A molecular risk score based on four functional pathways for advanced classical Hodgkin lymphoma. Blood 2010;116:e12–e17.
  • Montalbán C, García JF, Abraira V, . Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study Group. J Clin Oncol 2004;22:1664–1673.
  • Alvaro T, Lejeune M, Salvado MT, . Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005;11:1467–1473.
  • Morente MM, Piris MA, Abraira V, . Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 1997;90:2429–2436.
  • Steidl C, Lee T, Shah SP, . Tumor-associated macrophages and survival in classical Hodgkin's lymphoma. N Engl J Med 2010;362:875–885.
  • Tzankov A, Meier C, Hirschmann P, . Correlation of high numbers of intratumoral FOXP3 + regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 2008;93:193–200.
  • Kamper P, Bendix K, Hamilton-Dutoit S, . Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica 2011;96:269–276.
  • Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998;339:1506–1514.
  • Hasenclever D. The disappearance of prognostic factors in Hodgkin's disease. Ann Oncol 2002; 13(Suppl. 1):75–78.
  • Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11–21.
  • Franklin J, Paulus U, Lieberz D, . Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? Ann Oncol 2000;11:617–623.
  • Moccia AA, Donaldson J, Chhanabhai M, . The International Prognostic Factor Project score (IPS) in advanced stage Hodgkin lymphoma has limited utility in patients treated in the modern era. Blood 2009;114(Suppl. 1): Abstract 1554.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.